UFP Technologies, Inc. Deferred Tax Liabilities, Gross
UFP Technologies, Inc. (UFPT) had Deferred Tax Liabilities, Gross of $19.87 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-27
- 2025-12-31: Deferred Tax Liabilities, Gross $19.87M.
- 2024-12-31: Deferred Tax Liabilities, Gross $14.94M.
- 2023-12-31: Deferred Tax Liabilities, Gross $9.50M.
- 2022-12-31: Deferred Tax Liabilities, Gross $8.47M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $19.87M 10-K · filed 2026-02-27 |
| 2024-12-31 | $14.94M 10-K · filed 2026-02-27 |
| 2023-12-31 | $9.50M 10-K · filed 2025-03-03 |
| 2022-12-31 | $8.47M 10-K · filed 2024-02-29 |
| 2021-12-31 | $10.53M 10-K · filed 2023-03-16 |
| 2020-12-31 | $7.91M 10-K · filed 2022-03-14 |
| 2019-12-31 | $7.67M 10-K · filed 2021-03-12 |
| 2018-12-31 | $6.07M 10-K · filed 2020-03-13 |
| 2017-12-31 | $3.90M 10-K · filed 2019-03-15 |
| 2016-12-31 | $5.66M 10-K · filed 2018-03-16 |
| 2015-12-31 | $5.05M 10-K · filed 2017-03-10 |
| 2014-12-31 | $4.32M 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |